Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
2(18%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
8
73%
Ph phase_3
2
18%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
2(20.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(8)
Terminated(1)

Detailed Status

Completed8
Terminated1
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (20.0%)
N/A8 (80.0%)

Trials by Status

terminated19%
recruiting19%
active_not_recruiting19%
completed873%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11